Adiponectin is an adipokine, and its plasma levels are decreased in obesity [2], T2DM [3], insulin resistance [4], dyslipidemia [5], and coronary artery disease (CAD) [6]. This evidence concerns the gene ADIPOQ and metabolic syndrome.